Business
GREY WOLF ANIMAL HEALTH ANNOUNCES THE ACQUISITION OF THE COMPOUNDING PHARMACY OF MANITOBA
GREY WOLF ANIMAL HEALTH ANNOUNCES THE ACQUISITION OF THE COMPOUNDING PHARMACY OF MANITOBA ...
About this update from Grey Wolf Animal Health Corp
[{"type":"text","content":"\n\n\n\n GREY WOLF ANIMAL HEALTH ANNOUNCES THE ACQUISITION OF THE COMPOUNDING PHARMACY OF MANITOBA\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n Grey Wolf acquires a leading compounding pharmacy for\n \n $22.5 million\n \n\n\n\n\n Expands product mix and capacity for growth in Grey Wolf's pharmacy business unit\n \n\n\n\n Immediately accretive to revenue, Adjusted EBITDA and earnings per share\n \n\n\n\n Financed with a mix of cash on hand, debt from existing lender and shares issued to the vendors\n \n\n\n\n\n\n TORONTO\n \n\n ,\n \n\n Dec. 2, 2024\n \n\n /CNW/ - Grey Wolf Animal Health Corp. (TSXV: WOLF) (\"Grey Wolf\" or the \"Company\"), a Canadian diversified health company, today announced that it has completed the acquisition (the \"Transaction\") of 6303021 Manitoba Ltd. (dba.– The Compounding Pharmacy of\n \n Manitoba\n \n ) (\"CPM\") for total consideration of\n \n $22.5 million\n \n , including associated real estate, pursuant to a Share Purchase Agreement dated\n \n December 2, 2024\n \n .\n \n\n\n\n\n\n\n\n\n CPM operates a state-of-the-art facility located in\n \n Oakbank, Manitoba\n \n , and is a leading independent compounding pharmacy servicing both corporately owned and independent pharmacies, and veterinarians in\n \n Canada\n \n . CPM had revenues of approximately\n \n $6.4 million\n \n and Adjusted EBITDA of approximately\n \n $2.5 million\n \n , for the trailing twelve months ending\n \n September 30, 2024\n \n . All pro-forma numbers related to CPM referenced herein are unaudited figures.\n \n\n\n Highlights of the Transaction:\n \n\n\n\n New facility located in\n \n Manitoba\n \n is expected to provide greater scale and capacity for growth in the Company's pharmacy business unit\n \n\n Expected to further diversify the Company's customer mix ranging from independent and corporately owned pharmacies to veterinarians\n \n\n Expands the Company's product offerings in the human compounding market\n \n\n Expected to be immediately accretive to revenue, Adjusted EBITDA and earnings per share\n \n\n Total Con...